-
Giannis suitors make deals as NBA trade deadline nears
-
Carrick stresses significance of Munich air disaster to Man Utd history
-
Record January window for transfers despite drop in spending
-
'Burned inside their houses': Nigerians recount horror of massacre
-
Iran, US prepare for Oman talks after deadly protest crackdown
-
Winter Olympics opening ceremony nears as virus disrupts ice hockey
-
Mining giant Rio Tinto abandons Glencore merger bid
-
Davos forum opens probe into CEO Brende's Epstein links
-
ECB warns of stronger euro impact, holds rates
-
Famine spreading in Sudan's Darfur, warn UN-backed experts
-
Lights back on in eastern Cuba after widespread blackout
-
Russia, US agree to resume military contacts at Ukraine talks
-
Greece aims to cut queues at ancient sites with new portal
-
No time frame to get Palmer in 'perfect' shape - Rosenior
-
Stocks fall as tech valuation fears stoke volatility
-
US Olympic body backs LA28 leadership amid Wasserman scandal
-
Gnabry extends Bayern Munich deal until 2028
-
England captain Stokes suffers facial injury after being hit by ball
-
Italy captain Lamaro amongst trio set for 50th caps against Scotland
-
Piastri plays down McLaren rivalry with champion Norris
-
ECB holds interest rates as strong euro causes jitters
-
EU close to sealing trade deal with Australia
-
German Cup final to stay in Berlin until 2030
-
What does Iran want from talks with the US?
-
Taming the lion: Olympians take on Bormio's terrifying Stelvio piste
-
Wind turbine maker Vestas sees record revenue in 2025
-
Italy's Casse tops second Olympic downhill training
-
Anti-doping boss 'uncomfortable' with Valieva's coach at Olympics
-
Bitcoin under $70,000 for first time since Trump's election
-
'I am sorry,' embattled UK PM tells Epstein victims
-
England's Brook predicts record 300-plus scores at T20 World Cup
-
Ukraine, Russia swap prisoners, US says 'work remains' to end war
-
Wales' Rees-Zammit at full-back for Six Nations return against England
-
Sad horses and Draco Malfoy: China's unexpected Lunar New Year trends
-
Hong Kong students dissolve pro-democracy group under 'severe' pressure
-
Germany claws back 59 mn euros from Amazon over price controls
-
Germany claws back 70 mn euros from Amazon over price controls
-
VW and Stellantis urge help to keep carmaking in Europe
-
Stock markets drop amid tech concerns before rate calls
-
BBVA posts record profit after failed Sabadell takeover
-
UN human rights agency in 'survival mode': chief
-
Greenpeace slams fossil fuel sponsors for Winter Olympics
-
Greenpeace slams fossel fuel sponsors for Winter Olympics
-
Kinghorn, Van der Merwe dropped by Scotland for Six Nations opener
-
Russia says thwarted smuggling of giant meteorite to UK
-
Salt war heats up in ice-glazed Berlin
-
Liverpool in 'good place' for years to come, says Slot
-
Heathrow still Europe's busiest airport, but Istanbul gaining fast
-
Highest storm alert lifted in Spain, one woman missing
-
Shell profits climb despite falling oil prices
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
A.F.Rosado--PC